IMPC phenotypes (allele matching)
C57BL/6N-Ap2a2em1(IMPC)Wtsi/WtsiH
| Status | Available to order |
| EMMA ID | EM:11888 |
| International strain name | C57BL/6N-Ap2a2em1(IMPC)Wtsi/WtsiH |
| Alternative name | |
| Strain type | Endonuclease-mediated |
| Allele/Transgene symbol | Ap2a2em1(IMPC)Wtsi |
| Gene/Transgene symbol | Ap2a2 |
Information from provider
| Provider | Wellcome Trust Sanger Institute |
| Provider affiliation | Wellcome Trust Sanger Institute |
| Genetic information | This mouse line originates from CRISPR zygote microinjection. For further details see the project page at the IMPC portal. |
| Phenotypic information | Potential phenotyping data in the IMPC portal |
| References | None available |
Information from EMMA
| Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
- increased circulating cholesterol level / IMPC
- increased circulating iron level / IMPC
- decreased mean corpuscular hemoglobin / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- decreased circulating fructosamine level / IMPC
- increased circulating HDL cholesterol level / IMPC
- decreased circulating serum albumin level / IMPC
- increased circulating LDL cholesterol level / IMPC
- increased circulating alkaline phosphatase level / IMPC
- increased circulating free fatty acids level / IMPC
- absent pinna reflex / IMPC